STRUCTURE AND FUNCTION OF DIPHTHERIA TOXIN: FROM PATHOLOGY TO ENGINEERING

REFERENCES

• Gill D. M., Uchida T., Singer R. A. Expression of diphtheria toxin genes carried by integrated and nonintegrated phage beta. Virology 1972; 50: 664
   Google Scholar
• Holmes R. K. Biology and molecular epidemiology of diphtheria toxin and the tox gene. J. Infect. Dis. 2000; 181(Suppl. 1)S156
   PubMedGoogle Scholar
• Murphy J. R., Michel J. L., Teng M. Evidence that the regulation of diphtheria toxin production is directed at the level of transcription. J. Bacteriol. 1978; 135: 511
   Google Scholar
• Collier R. J. Understanding the mode of action of diphtheria toxin: A perspective on progress during the 20th century. Toxicon 2001; 39: 1793
   PubMed Web of Science ®Google Scholar
• Loeffler F. Untersuchungen Uber De Bedeutung Der Mikroorganismen Fur Die Entstehung Der Diphtherie Beim Menschen, Bei Der Taube Und Beim Kalbe. Mitt. Klin. Gesundheitsamte, Berlin 1884; 2: 421
   Google Scholar
• Roux E., Jr., Yersin A. Contribution a l'Etude de la Diphterie. Ann. Inst. Pasteur 1888; 2: 620
   Google Scholar
• Behring E. Untersuchungen Uber Das Zustandekommen Der Diphtherie-Immunitat Bei Theiren. Dtsch. Med. Wochenschr. 1890; 16: 1145
   Google Scholar
• Grundbacher F. J. Behring's discovery of diphtheria and tetanus antitoxins. Immunol. Today 1992; 13: 188
   PubMedGoogle Scholar
• Ramon G., Jr. Sur Le Pouvoir Floculant et sur les Proprietes Immunisantes d'une Toxine Diphterique Rendue Anatoxique (Anatoxine). C. R. Acad. Sci. 1923; 177: 1330
   Google Scholar
• Eaton M. D. The purification and concentration of diphtheria toxin. J. Bacteriol. 1936; 31: 347
   Google Scholar
• Pappenheimer A. M., Jr. Diphtheria toxin—I: Isolation and characterization of a toxic protein from C. diphtheriae filtrates. J. Biol. Chem. 1937; 125: 543
   Google Scholar
• Kaczorek M., Delpeyroux F., Chenciner N., Streeck R. E., Murphy J. R., Boquet P., Tiollais P. Nucleotide sequence and expression of the diphtheria tox228 gene in Escherichia coli. Science 1983; 221: 855
   PubMedGoogle Scholar
• Greenfield L., Bjorn M. J., Horn G., Fong D., Buck G. A., Collier R. J., Kaplan D. A. Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage beta. Proc. Natl. Acad. Sci. U. S. A. 1983; 80: 6853
   PubMedGoogle Scholar
• Choe S., Bennett M. J., Fujii G., Curmi P. M., Kantardjieff K. A., Collier R. J., Eisenberg D. The crystal structure of diphtheria toxin. Nature 1992; 357: 216
   PubMed Web of Science ®Google Scholar
• Murphy J. R., Bishai W., Borowski M., Miyanohara A., Boyd J., Nagle S. Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 8258
   PubMed Web of Science ®Google Scholar
• Bennett M. J., Eisenberg D. Refined structure of monomeric diphtheria toxin at 2.3 Å resolution. Protein Sci. 1994; 3: 1464
   PubMedGoogle Scholar
• Bennett M. J., Choe S., Eisenberg D. Refined structure of dimeric diphtheria toxin at 2.0 Å resolution. Protein Sci. 1994; 3: 1444
   PubMed Web of Science ®Google Scholar
• Bell C. E., Eisenberg D. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide. Biochemistry 1996; 35: 1137
   PubMed Web of Science ®Google Scholar
• Louie G. V., Yang W., Bowman M. E., Choe S. Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor. Mol. Cell 1997; 1: 67
   Google Scholar
• Menestrina G., Schiavo G., Montecucco C. Molecular mechanisms of action of bacterial protein toxins. Mol. Aspects Med. 1994; 15: 79
   Google Scholar
• Holm L., Sander C. Globin fold in a bacterial toxin. Nature 1993; 361: 309
   Google Scholar
• Reed J. C. Double identity for proteins of the Bcl-2 family. Nature 1997; 387: 773
   PubMed Web of Science ®Google Scholar
• Naglich J. G., Metherall J. E., Russell D. W., Eidels L. Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69: 1051
   PubMed Web of Science ®Google Scholar
• Tsuneoka M., Nakayama K., Hatsuzawa K., Komada M., Kitamura N., Mekada E. Evidence for involvement of furin in cleavage and activation of diphtheria toxin. J. Biol. Chem. 1993; 268: 26461
   PubMed Web of Science ®Google Scholar
• Keen J. H., Maxfield F. R., Hardegree M. C., Habig W. H. Receptor-mediated endocytosis of diphtheria toxin by cells in culture. Proc. Natl. Acad. Sci. U. S. A. 1982; 79: 2912
   PubMed Web of Science ®Google Scholar
• Moya M., Dautry-Varsat A., Goud B., Louvard D., Boquet P. Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin. J. Cell Biol. 1985; 101: 548
   PubMed Web of Science ®Google Scholar
• Morris R. E., Gerstein A. S., Bonventre P. F., Saelinger C. B. Receptor-mediated entry of diphtheria toxin into monkey kidney (vero) cells: Electron microscopic evaluation. Infect. Immun. 1985; 50: 721
   PubMed Web of Science ®Google Scholar
• London E. Diphtheria toxin: Membrane interaction and membrane translocation. Biochim. Biophys. Acta 1992; 1113: 25
   Google Scholar
• London E. How bacterial protein toxins enter cells; the role of partial unfolding in membrane translocation. Mol. Microbiol. 1992; 6: 3277
   Google Scholar
• Draper R. K., Simon M. I. The entry of diphtheria toxin into the mammalian cell cytoplasm: Evidence for lysosomal involvement. J. Cell Biol. 1980; 87: 849
   Google Scholar
• Sandvig K., Olsnes S. Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule. J. Biol. Chem. 1981; 256: 9068
   PubMed Web of Science ®Google Scholar
• Sandvig K., Olsnes S. Diphtheria toxin entry into cells is facilitated by low pH. J. Cell Biol. 1980; 87: 828
   PubMedGoogle Scholar
• Lemichez E., Bomsel M., Devilliers G., vanderSpek J., Murphy J. R., Lukianov E. V., Olsnes S., Boquet P. Membrane translocation of diphtheria toxin fragment a exploits early to late endosome trafficking machinery. Mol. Microbiol. 1997; 23: 445
   PubMed Web of Science ®Google Scholar
• Falnes P. O., Olsnes S. Cell-mediated reduction and incomplete membrane translocation of diphtheria toxin mutants with internal disulfides in the A fragment. J. Biol. Chem. 1995; 270: 20787
   Google Scholar
• Honjo T., Nishizuka Y., Hayaishi O. Diphtheria toxin-dependent adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis. J. Biol. Chem. 1968; 243: 3553
   PubMed Web of Science ®Google Scholar
• Collier R. J. Effect of diphtheria toxin on protein synthesis: Inactivation of one of the transfer factors. J. Mol. Biol. 1967; 25: 83
   PubMed Web of Science ®Google Scholar
• Collier R. J., Cole H. A. Diphtheria toxin subunit active in vitro. Science 1969; 164: 1179
   Google Scholar
• Van Ness B. G., Howard J. B., Bodley J. W. ADP-ribosylation of elongation factor 2 by diphtheria toxin. NMR spectra and proposed structures of ribosyl-diphthamide and its hydrolysis products. J. Biol. Chem. 1980; 255: 10710
   PubMed Web of Science ®Google Scholar
• Van Ness B. G., Howard J. B., Bodley J. W. ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. J. Biol. Chem. 1980; 255: 10717
   PubMed Web of Science ®Google Scholar
• Higashiyama S., Abraham J. A., Miller J., Fiddes J. C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251: 936
   PubMed Web of Science ®Google Scholar
• Higashiyama S., Lau K., Besner G. E., Abraham J. A., Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 1992; 267: 6205
   PubMed Web of Science ®Google Scholar
• Mitamura T., Higashiyama S., Taniguchi N., Klagsbrun M., Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 1995; 270: 1015
   PubMed Web of Science ®Google Scholar
• Mitamura T., Umata T., Nakano F., Shishido Y., Toyoda T., Itai A., Kimura H., Mekada E. Structure–function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis. J. Biol. Chem. 1997; 272: 27084
   Google Scholar
• Hooper K. P., Eidels L. Glutamic acid 141 of the diphtheria toxin receptor (HB-EGF precursor) is critical for toxin binding and toxin sensitivity. Biochem. Biophys. Res. Commun. 1996; 220: 675
   Google Scholar
• Cha J. H., Brooke J. S., Eidels L. Toxin binding site of the diphtheria toxin receptor: Loss and gain of diphtheria toxin binding of monkey and mouse heparin-binding, epidermal growth factor-like growth factor precursors by reciprocal site-directed mutagenesis. Mol. Microbiol. 1998; 29: 1275
   Google Scholar
• Middlebrook J. L., Dorland R. B. Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: Differential cytotoxicity. Can. J. Microbiol. 1977; 23: 183
   PubMedGoogle Scholar
• Brown J. G., Almond B. D., Naglich J. G., Eidels L. Hypersensitivity to diphtheria toxin by mouse cells expressing both diphtheria toxin receptor and CD9 antigen. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 8184
   PubMed Web of Science ®Google Scholar
• Iwamoto R., Higashiyama S., Mitamura T., Taniguchi N., Klagsbrun M., Mekada E. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein Drap27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 1994; 13: 2322
   PubMed Web of Science ®Google Scholar
• Cha J. H., Brooke J. S., Ivey K. N., Eidels L. Cell surface monkey CD9 antigen is a coreceptor that increases diphtheria toxin sensitivity and diphtheria toxin receptor affinity. J. Biol. Chem. 2000; 275: 6901
   Google Scholar
• Nakamura K., Mitamura T., Takahashi T., Kobayashi T., Mekada E. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J. Biol. Chem. 2000; 275: 18284
   Google Scholar
• Hasuwa H., Shishido Y., Yamazaki A., Kobayashi T., Yu X., Mekada E. CD9 amino acids critical for upregulation of diphtheria toxin binding. Biochem. Biophys. Res. Commun. 2001; 289: 782
   Google Scholar
• Middlebrook J. L., Dorland R. B., Leppla S. H. Association of diphtheria toxin with vero cells. Demonstration of a receptor. J. Biol. Chem. 1978; 253: 7325
   PubMedGoogle Scholar
• Brooke J. S., Cha J. H., Eidels L. Diphtheria toxin: Receptor interaction: Association, dissociation, and effect of pH. Biochem. Biophys. Res. Commun. 1998; 248: 297
   Google Scholar
• Shen W. H., Choe S., Eisenberg D., Collier R. J. Participation of lysine 516 and phenylalanine 530 of diphtheria toxin in receptor recognition. J. Biol. Chem. 1994; 269: 29077
   Google Scholar
• Greenfield L., Johnson V. G., Youle R. J. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity. Science 1987; 238: 536
   PubMed Web of Science ®Google Scholar
• Carroll S. F., Barbieri J. T., Collier R. J. Dimeric form of diphtheria toxin: Purification and characterization. Biochemistry 1986; 25: 2425
   Google Scholar
• Collier R. J., Kandel J. Structure and activity of diphtheria toxin. I. Thiol-dependent dissociation of a fraction of toxin into enzymically active and inactive fragments. J. Biol. Chem. 1971; 246: 1496
   PubMed Web of Science ®Google Scholar
• Drazin R., Kandel J., Collier R. J. Structure and activity of diphtheria toxin. II. Attack by trypsin at a specific site within the intact toxin molecule. J. Biol. Chem. 1971; 246: 1504
   PubMed Web of Science ®Google Scholar
• Gill D. M., Dinius L. L. Observations on the structure of diphtheria toxin. J. Biol. Chem. 1971; 246: 1485
   PubMed Web of Science ®Google Scholar
• Gill D. M., Pappenheimer A. M., Jr. Structure–activity relationships in diphtheria toxin. J. Biol. Chem. 1971; 246: 1492
   PubMed Web of Science ®Google Scholar
• Chiron M. F., Fryling C. M., FitzGerald D. J. Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. J. Biol. Chem. 1994; 269: 18167
   PubMed Web of Science ®Google Scholar
• Gordon V. M., Klimpel K. R., Arora N., Henderson M. A., Leppla S. H. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect. Immun. 1995; 63: 82
   PubMed Web of Science ®Google Scholar
• Sucic J. F., Moehring J. M., Inocencio N. M., Luchini J. W., Moehring T. J. Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain. Biochem. J. 1999; 339: 639
   PubMed Web of Science ®Google Scholar
• Williams D. P., Wen Z., Watson R. S., Boyd J., Strom T. B., Murphy J. R. Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. J. Biol. Chem. 1990; 265: 20673
   PubMed Web of Science ®Google Scholar
• Carroll S. F., Barbieri J. T., Collier R. J. Diphtheria toxin: Purification and properties. Methods Enzymol. 1988; 165: 68
   PubMed Web of Science ®Google Scholar
• Papini E., Rappuoli R., Murgia M., Montecucco C. Cell penetration of diphtheria toxin. Reduction of the interchain disulfide bridge is the rate-limiting step of translocation in the cytosol. J. Biol. Chem. 1993; 268: 1567
   Google Scholar
• Ronnberg B. J., Middlebrook J. L. Cellular regulation of diphtheria toxin cell surface receptors. Toxicon 1989; 27: 1377
   Google Scholar
• Quertenmont P., Wolff C., Wattiez R., Vander Borght P., Falmagne P., Ruysschaert J. M., Cabiaux V. Structure and topology of diphtheria toxin R domain in lipid membranes. Biochemistry 1999; 38: 660
   Google Scholar
• Tortorella D., Sesardic D., Dawes C. S., London E. Immunochemical analysis shows all three domains of diphtheria toxin penetrate across model membranes. J. Biol. Chem. 1995; 270: 27446
   Google Scholar
• Aniento F., Gu F., Parton R. G., Gruenberg J. An endosomal beta COP is involved in the pH-dependent formation of transport vesicles destined for late endosomes. J. Cell Biol. 1996; 133: 29
   PubMed Web of Science ®Google Scholar
• Yamaizumi M., Mekada E., Uchida T., Okada Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 1978; 15: 245
   PubMed Web of Science ®Google Scholar
• Falnes P. O., Ariansen S., Sandvig K., Olsnes S. Requirement for prolonged action in the cytosol for optimal protein synthesis inhibition by diphtheria toxin. J. Biol. Chem. 2000; 275: 4363
   Google Scholar
• Blewitt M. G., Chao J. M., McKeever B., Sarma R., London E. Fluorescence characterization of the low pH-induced change in diphtheria toxin conformation: Effect of salt. Biochem. Biophys. Res. Commun. 1984; 120: 286
   Google Scholar
• Blewitt M. G., Chung L. A., London E. Effect of pH on the conformation of diphtheria toxin and its implications for membrane penetration. Biochemistry 1985; 24: 5458
   PubMed Web of Science ®Google Scholar
• Zhao J. M., London E. Similarity of the conformation of diphtheria toxin at high temperature to that in the membrane-penetrating low-pH state. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 2002
   Google Scholar
• Tortorella D., Sesardic D., Dawes C. S., London E. Immunochemical analysis of the structure of diphtheria toxin shows all three domains undergo structural changes at low pH. J. Biol. Chem. 1995; 270: 27439
   Google Scholar
• D'Silva P. R., Lala A. K. Unfolding of diphtheria toxin. Identification of hydrophobic sites exposed on lowering of pH by photolabeling. J. Biol. Chem. 1998; 273: 16216
   Google Scholar
• Weiss M. S., Blanke S. R., Collier R. J., Eisenberg D. Structure of the isolated catalytic domain of diphtheria toxin. Biochemistry 1995; 34: 773
   Google Scholar
• Zhao J. M., London E. Conformation and model membrane interactions of diphtheria toxin fragment A. J. Biol. Chem. 1988; 263: 15369
   Google Scholar
• Murphy J. R., vanderSpek J. C. Targeting diphtheria toxin to growth factor receptors. Semin. Cancer Biol. 1995; 6: 259
   Google Scholar
• Parker M. W., Pattus F. Rendering a membrane protein soluble in water: A common packing motif in bacterial protein toxins. Trends Biochem. Sci. 1993; 18: 391
   Google Scholar
• Zhan H., Choe S., Huynh P. D., Finkelstein A., Eisenberg D., Collier R. J. Dynamic transitions of the transmembrane domain of diphtheria toxin: Disulfide trapping and fluorescence proximity studies. Biochemistry 1994; 33: 11254
   Google Scholar
• Malenbaum S. E., Collier R. J., London E. Membrane topography of the T domain of diphtheria toxin probed with single tryptophan mutants. Biochemistry 1998; 37: 17915
   Google Scholar
• Wang Y., Malenbaum S. E., Kachel K., Zhan H., Collier R. J., London E. Identification of shallow and deep membrane-penetrating forms of diphtheria toxin T domain that are regulated by protein concentration and bilayer width. J. Biol. Chem. 1997; 272: 25091
   PubMed Web of Science ®Google Scholar
• Chenal A., Nizard P., Forge V., Pugnière M., Roy M.-O., Mani J.-C., Guillain F., Gillet D. Does fusion of domains from unrelated proteins affect their folding pathways and the structure changes involved in their function? A case study with the diphtheria toxin T domain. Protein Eng., in press
   Google Scholar
• Kuwajima K. The molten globule state of alpha-lactalbumin. FASEB J. 1996; 10: 102
   PubMed Web of Science ®Google Scholar
• Ptitsyn O. B. The Molten Globule State, T. E. Creighton. Freeman, New York 1992; 243
   Google Scholar
• Falnes P. O., Madshus I. H., Sandvig K., Olsnes S. Replacement of negative by positive charges in the presumed membrane-inserted part of diphtheria toxin B fragment. Effect on membrane translocation and on formation of cation channels. J. Biol. Chem. 1992; 267: 12284
   Google Scholar
• Silverman J. A., Mindell J. A., Finkelstein A., Shen W. H., Collier R. J. Mutational analysis of the helical hairpin region of diphtheria toxin transmembrane domain. J. Biol. Chem. 1994; 269: 22524
   PubMed Web of Science ®Google Scholar
• Umata T., Mekada E. Diphtheria toxin translocation across endosome membranes. A novel cell permeabilization assay reveals new diphtheria toxin fragments in endocytic vesicles. J. Biol. Chem. 1998; 273: 8351
   Google Scholar
• Kaul P., Silverman J., Shen W. H., Blanke S. R., Huynh P. D., Finkelstein A., Collier R. J. Roles of Glu 349 and Asp 352 in membrane insertion and translocation by diphtheria toxin. Protein Sci. 1996; 5: 687
   PubMed Web of Science ®Google Scholar
• O'Keefe D. O., Cabiaux V., Choe S., Eisenberg D., Collier R. J. pH-Dependent insertion of proteins into membranes: B-chain mutation of diphtheria toxin that inhibits membrane translocation, Glu-349-Lys. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 6202
   Google Scholar
• Ren J., Sharpe J. C., Collier R. J., London E. Membrane translocation of charged residues at the tips of hydrophobic helices in the T domain of diphtheria toxin. Biochemistry 1999; 38: 976
   PubMed Web of Science ®Google Scholar
• Donovan J. J., Simon M. I., Draper R. K., Montal M. Diphtheria toxin forms transmembrane channels in planar lipid bilayers. Proc. Natl. Acad. Sci. U. S. A. 1981; 78: 172
   PubMed Web of Science ®Google Scholar
• Kagan B. L., Finkelstein A., Colombini M. Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes. Proc. Natl. Acad. Sci. U. S. A. 1981; 78: 4950
   PubMed Web of Science ®Google Scholar
• Papini E., Sandona D., Rappuoli R., Montecucco C. On the membrane translocation of diphtheria toxin: At low pH the toxin induces ion channels on cells. EMBO J. 1988; 7: 3353
   Google Scholar
• Sandvig K., Olsnes S. Diphtheria toxin-induced channels in vero cells selective for monovalent cations. J. Biol. Chem. 1988; 263: 12352
   Google Scholar
• Eriksen S., Olsnes S., Sandvig K., Sand O. Diphtheria toxin at low pH depolarizes the membrane, increases the membrane conductance and induces a new type of ion channel in vero cells. EMBO J. 1994; 13: 4433
   Google Scholar
• Olsnes S., Moskaug J. O., Stenmark H., Sandvig K. Translocation of diphtheria toxin to the cytosol and formation of cation selective channels. J. Physiol. 1990; 84: 191
   Google Scholar
• Montecucco C., Papini E., Schiavo G., Padovan E., Rossetto O. Ion channel and membrane translocation of diphtheria toxin. FEMS Microbiol. Immunol. 1992; 5: 101
   PubMedGoogle Scholar
• Zhan H., Oh K. J., Shin Y. K., Hubbell W. L., Collier R. J. Interaction of the isolated transmembrane domain of diphtheria toxin with membranes. Biochemistry 1995; 34: 4856
   Google Scholar
• Oh K. J., Zhan H., Cui C., Hideg K., Collier R. J., Hubbell W. L. Organization of diphtheria toxin T domain in bilayers: A site-directed spin labeling study. Science 1996; 273: 810
   PubMed Web of Science ®Google Scholar
• Oh K. J., Zhan H., Cui C., Altenbach C., Hubbell W. L., Collier R. J. Conformation of the diphtheria toxin T domain in membranes: A site-directed spin-labeling study of the TH8 helix and TL5 loop. Biochemistry 1999; 38: 10336
   Google Scholar
• D'Silva P. R., Lala A. K. Organization of diphtheria toxin in membranes. A hydrophobic photolabeling study. J. Biol. Chem. 2000; 275: 11771
   Google Scholar
• Hu H. Y., Huynh P. D., Murphy J. R., vanderSpek J. C. The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389-IL-2. Protein Eng. 1998; 11: 811
   PubMedGoogle Scholar
• Silverman J. A., Mindell J. A., Zhan H., Finkelstein A., Collier R. J. Structure–function relationships in diphtheria toxin channels: I. Determining a minimal channel-forming domain. J. Membr. Biol. 1994; 137: 17
   PubMed Web of Science ®Google Scholar
• Cabiaux V., Quertenmont P., Conrath K., Brasseur R., Capiau C., Ruysschaert J. M. Topology of diphtheria toxin B fragment inserted in lipid vesicles. Mol. Microbiol. 1994; 11: 43
   Google Scholar
• Quertenmont P., Wattiez R., Falmagne P., Ruysschaert J. M., Cabiaux V. Topology of diphtheria toxin in lipid vesicle membranes: A proteolysis study. Mol. Microbiol. 1996; 21: 1283
   Google Scholar
• Kachel K., Ren J., Collier R. J., London E. Identifying transmembrane states and defining the membrane insertion boundaries of hydrophobic helices in membrane-inserted diphtheria toxin T domain. J. Biol. Chem. 1998; 273: 22950
   Google Scholar
• Senzel L., Gordon M., Blaustein R. O., Oh K. J., Collier R. J., Finkelstein A. Topography of diphtheria toxin's T domain in the open channel state. J. Gen. Physiol. 2000; 115: 421
   Google Scholar
• Mindell J. A., Silverman J. A., Collier R. J., Finkelstein A. Locating a residue in the diphtheria toxin channel. Biophys. J. 1992; 62: 41
   Google Scholar
• Mindell J. A., Silverman J. A., Collier R. J., Finkelstein A. Structure–function relationships in diphtheria toxin channels: III. Residues which affect the cis pH dependence of channel conductance. J. Membr. Biol. 1994; 137: 45
   Google Scholar
• Mindell J. A., Silverman J. A., Collier R. J., Finkelstein A. Structure function relationships in diphtheria toxin channels: II. A residue responsible for the channel's dependence on trans pH. J. Membr. Biol. 1994; 137: 29
   Google Scholar
• Madshus I. H. The N-terminal alpha-helix of fragment B of diphtheria toxin promotes translocation of fragment A into the cytoplasm of eukaryotic cells. J. Biol. Chem. 1994; 269: 17723
   Google Scholar
• Madshus I. H., Wiedlocha A., Sandvig K. Intermediates in translocation of diphtheria toxin across the plasma membrane. J. Biol. Chem. 1994; 269: 4648
   Google Scholar
• Senzel L., Huynh P. D., Jakes K. S., Collier R. J., Finkelstein A. The diphtheria toxin channel-forming T domain translocates its own NH2-terminal region across planar bilayers. J. Gen. Physiol. 1998; 112: 317
   Google Scholar
• Nizard P., Chenal A., Beaumelle B., Fourcade A., Gillet D. Prolonged display or rapid internalization of the IgG-binding protein ZZ anchored to the surface of cells using the diphtheria toxin T domain. Protein Eng. 2001; 14: 439
   Google Scholar
• Bell C. E., Poon P. H., Schumaker V. N., Eisenberg D. Oligomerization of a 45 kilodalton fragment of diphtheria toxin at pH 5.0 to a molecule of 20–24 subunits. Biochemistry 1997; 36: 15201
   PubMed Web of Science ®Google Scholar
• Steere B., Eisenberg D. Characterization of high-order diphtheria toxin oligomers. Biochemistry 2000; 39: 15901
   Google Scholar
• Sharpe J. C., London E. Diphtheria toxin forms pores of different sizes depending on its concentration in membranes: Probable relationship to oligomerization. J. Membr. Biol. 1999; 171: 209
   Google Scholar
• Gordon M., Finkelstein A. The number of subunits comprising the channel formed by the T domain of diphtheria toxin. J. Gen. Physiol. 2001; 118: 471
   Google Scholar
• Huynh P. D., Cui C., Zhan H., Oh K. J., Collier R. J., Finkelstein A. Probing the structure of the diphtheria toxin channel. Reactivity in planar lipid bilayer membranes of cysteine-substituted mutant channels with methanethiosulfonate derivatives. J. Gen. Physiol. 1997; 110: 229
   Google Scholar
• Olsnes S., Falnes P. O. Probing pores with peptide plugs. Topology of membrane-inserted diphtheria toxin. J. Gen. Physiol. 2000; 115: 417
   Google Scholar
• Korchev Y. E., Bashford C. L., Pederzolli C., Pasternak C. A., Morgan P. J., Andrew P. W., Mitchell T. J. A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem. J. 1998; 329: 571
   PubMedGoogle Scholar
• Menzl K., Maier E., Chakraborty T., Benz R. HlyA hemolysin of Vibrio cholerae O1 biotype E1 tor. Identification of the hemolytic complex and evidence for the formation of anion-selective ion-permeable channels. Eur. J. Biochem. 1996; 240: 646
   Google Scholar
• Maier E., Reinhard N., Benz R., Frey J. Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae. Infect. Immun. 1996; 64: 4415
   Google Scholar
• Slatin S. L., Abrams C. K., English L. Delta-endotoxins form cation-selective channels in planar lipid bilayers. Biochem. Biophys. Res. Commun. 1990; 169: 765
   PubMedGoogle Scholar
• vanderSpek J. C., Mindell J. A., Finkelstein A., Murphy J. R. Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. J. Biol. Chem. 1993; 268: 12077
   PubMed Web of Science ®Google Scholar
• vanderSpek J. C., Howland K., Friedman T., Murphy J. R. Maintenance of the hydrophobic face of the diphtheria toxin amphipathic transmembrane helix 1 is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. Protein Eng. 1994; 7: 985
   Google Scholar
• vanderSpek J., Cassidy D., Genbauffe F., Huynh P. D., Murphy J. R. An intact transmembrane helix 9 is essential for the efficient delivery of the diphtheria toxin catalytic domain to the cytosol of target cells. J. Biol. Chem. 1994; 269: 21455
   PubMed Web of Science ®Google Scholar
• Oh K. J., Senzel L., Collier R. J., Finkelstein A. Translocation of the catalytic domain of diphtheria toxin across planar phospholipid bilayers by its own T domain. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 8467
   PubMed Web of Science ®Google Scholar
• Falnes P. O., Choe S., Madshus I. H., Wilson B. A., Olsnes S. Inhibition of membrane translocation of diphtheria toxin A—Fragment by internal disulfide bridges. J. Biol. Chem. 1994; 269: 8402
   PubMedGoogle Scholar
• Falnes P. O., Sandvig K. Penetration of protein toxins into cells. Curr. Opin. Cell Biol. 2000; 12: 407
   PubMed Web of Science ®Google Scholar
• Ren J., Kachel K., Kim H., Malenbaum S. E., Collier R. J., London E. Interaction of diphtheria toxin T domain with molten globule-like proteins and its implications for translocation. Science 1999; 284: 955
   PubMed Web of Science ®Google Scholar
• Klingenberg O., Olsnes S. Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin. Biochem. J. 1996; 313: 647
   Google Scholar
• Wiedlocha A., Madshus I. H., Mach H., Middaugh C. R., Olsnes S. Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector. EMBO J. 1992; 11: 4835
   PubMed Web of Science ®Google Scholar
• Kandel J., Collier R. J., Chung D. W. Interaction of fragment A from diphtheria toxin with nicotinamide adenine dinucleotides. J. Biol. Chem. 1974; 249: 2088
   Google Scholar
• Gehrmann R., Henschen A., Klink F. Primary structure of elongation factor 2 around the site of ADP-ribosylation is highly conserved from archaebacteria to eukaryotes. FEBS Lett. 1985; 185: 37
   Google Scholar
• Phan L. D., Perentesis J. P., Bodley J. W. Saccharomyces cerevisiae elongation factor 2. Mutagenesis of the histidine precursor of diphthamide yields a functional protein that is resistant to diphtheria toxin. J. Biol. Chem. 1993; 268: 8665
   PubMed Web of Science ®Google Scholar
• Iglewski W. J. Cellular ADP-ribosylation of elongation factor 2. Mol. Cell Biochem. 1994; 138: 131
   Google Scholar
• Fendrick J. L., Iglewski W. J. Endogenous ADP-ribosylation of elongation factor 2 in polyoma virus-transformed baby hamster kidney cells. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 554
   PubMedGoogle Scholar
• Kimata Y., Kohno K. Elongation factor 2 mutants deficient in diphthamide formation show temperature-sensitive cell growth. J. Biol. Chem. 1994; 269: 13497
   PubMedGoogle Scholar
• Papini E., Schiavo G., Sandona D., Rappuoli R., Montecucco C. Histidine 21 is at the NAD+ binding site of diphtheria toxin. J. Biol. Chem. 1989; 264: 12385
   Google Scholar
• Blanke S. R., Huang K., Wilson B. A., Papini E., Covacci A., Collier R. J. Active-site mutations of the diphtheria toxin catalytic domain: Role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2. Biochemistry 1994; 33: 5155
   Google Scholar
• Johnson V. G., Nicholls P. J. Histidine 21 does not play a major role in diphtheria toxin catalysis. J. Biol. Chem. 1994; 269: 4349
   Google Scholar
• Papini E., Santucci A., Schiavo G., Domenighini M., Neri P., Rappuoli R., Montecucco C. Tyrosine 65 is photolabeled by 8-azidoadenine and 8-azidoadenosine at the NAD binding site of diphtheria toxin. J. Biol. Chem. 1991; 266: 2494
   Google Scholar
• Blanke S. R., Huang K., Collier R. J. Active-site mutations of diphtheria toxin: Role of tyrosine-65 in NAD binding and ADP-ribosylation. Biochemistry 1994; 33: 15494
   PubMed Web of Science ®Google Scholar
• Carroll S. F., McCloskey J. A., Crain P. F., Oppenheimer N. J., Marschner T. M., Collier R. J. Photoaffinity labeling of diphtheria toxin fragment A with NAD: Structure of the photoproduct at position 148. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 7237
   PubMedGoogle Scholar
• Carroll S. F., Collier R. J. NAD binding site of diphtheria toxin: Identification of a residue within the nicotinamide subsite by photochemical modification with NAD. Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 3307
   Google Scholar
• Chung D. W., Collier R. J. The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin. Biochim. Biophys. Acta 1977; 483: 248
   PubMed Web of Science ®Google Scholar
• Wilson B. A., Reich K. A., Weinstein B. R., Collier R. J. Active-site mutations of diphtheria toxin: Effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine. Biochemistry 1990; 29: 8643
   PubMedGoogle Scholar
• Wilson B. A., Collier R. J. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: Active-site structure and enzymic mechanism. Curr. Top. Microbiol. Immunol. 1992; 175: 27
   Google Scholar
• Paliwal R., London E. Comparison of the conformation, hydrophobicity, and model membrane interactions of diphtheria toxin to those of formaldehyde-treated toxin (Diphtheria toxoid): Formaldehyde stabilization of the native conformation inhibits changes that allow membrane insertion. Biochemistry 1996; 35: 2374
   PubMed Web of Science ®Google Scholar
• Foss F. M. DAB[389]IL-2 (ONTAK): A novel fusion toxin therapy for lymphoma. Clin. Lymphoma 2000; 1: 110
   PubMedGoogle Scholar
• Hall P. D., Virella G., Willoughby T., Atchley D. H., Kreitman R. J., Frankel A. E. Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia. Clin. Immunol. 2001; 100: 191
   PubMed Web of Science ®Google Scholar
• Stenmark H., Moskaug J. O., Madshus I. H., Sandvig K., Olsnes S. Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol. J. Cell Biol. 1991; 113: 1025
   PubMed Web of Science ®Google Scholar
• Madshus I. H., Olsnes S., Stenmark H. Membrane translocation of diphtheria toxin carrying passenger protein domains. Infect. Immun. 1992; 60: 3296
   Google Scholar
• Sundan A., Olsnes S., Sandvig K., Pihl A. Preparation and properties of chimeric toxins prepared from the constituent polypeptides of diphtheria toxin and ricin. Evidence for entry of ricin A-chain via the diphtheria toxin pathway. J. Biol. Chem. 1982; 257: 9733
   Google Scholar
• Aullo P., Giry M., Olsnes S., Popoff M. R., Kocks C., Boquet P. A chimeric toxin to study the role of the 21 kDa GTP binding protein rho in the control of actin microfilament assembly. EMBO J. 1993; 12: 921
   Google Scholar
• Liger D., Nizard P., Gaillard C., vanderSpek J. C., Murphy J. R., Pitard B., Gillet D. The diphtheria toxin transmembrane domain as a pH sensitive membrane anchor for human interleukin-2 and murine interleukin-3. Protein Eng. 1998; 11: 1111
   Google Scholar
• Nizard P., Liger D., Gaillard C., Gillet D. Anchoring antibodies to membranes using a diphtheria toxin T domain-ZZ fusion protein as a pH sensitive membrane anchor. FEBS Lett. 1998; 433: 83
   Google Scholar
• Nizard P., Gross D. A., Chenal A., Beaumelle B., Kosmatopoulos K., Gillet D. Ancrer des Cytokines aux Cellules Cancereuses a l'Aide de la Toxine Diphterique: Mieux Que l'Immunotherapie par Transfert de Gene?. J. Soc. Biol. 2001; 195: 229
   Google Scholar
• Nizard P., Gross D. A., Chenal A., Beaumelle B., Kosmatopoulos K., Gillet D. Anchoring cytokines to cancer cells using a protein membrane anchor: An alternative to gene transfer for vaccine preparation. Cancer Gene Ther. 2000; 7: 1203
   Google Scholar
• Dinges M. M., Cook D. R., King J., Curiel T. J., Zhang X. Q., Harrison G. S. HIV-regulated diphtheria toxin A chain gene confers long-term protection against HIV type 1 infection in the human promonocytic cell line U937. Hum. Gene Ther. 1995; 6: 1437
   Google Scholar
• Saito M., Iwawaki T., Taya C., Yonekawa H., Noda M., Inui Y., Mekada E., Kimata Y., Tsuru A., Kohno K. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 2001; 19: 746
   PubMed Web of Science ®Google Scholar
• Audibert F., Jolivet M., Chedid L., Alouf J. E., Boquet P., Rivaille P., Siffert O. Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide. Nature 1981; 289: 593
   PubMed Web of Science ®Google Scholar
• Boquet P., Alouf J. E., Duflot E., Siffert O., Rivaille P. Characteristics of guinea-pig immune sera elicited by a synthetic diphtheria toxin oligopeptide. Mol. Immunol. 1982; 19: 1541
   Google Scholar
• Lobeck K., Drevet P., Leonetti M., Fromen-Romano C., Ducancel F., Lajeunesse E., Lemaire C., Menez A. Towards a recombinant vaccine against diphtheria toxin. Infect. Immun. 1998; 66: 418
   Google Scholar
• Fisher K. J., Wilson J. M. The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. Biochem. J. 1997; 321: 49
   PubMed Web of Science ®Google Scholar
• Uherek C., Fominaya J., Wels W. A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery. J. Biol. Chem. 1998; 273: 8835
   PubMed Web of Science ®Google Scholar
• Williams D. P., Parker K., Bacha P., Bishai W., Borowski M., Genbauffe F., Strom T. B., Murphy J. R. Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Eng. 1987; 1: 493
   PubMedGoogle Scholar
• Hesketh P., Caguioa P., Koh H., Dewey H., Facada A., McCaffrey R., Parker K., Nylen P., Woodworth T. Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma. J. Clin. Oncol. 1993; 11: 1682
   PubMed Web of Science ®Google Scholar
• LeMaistre C. F., Saleh M. N., Kuzel T. M., Foss F., Platanias L. C., Schwartz G., Ratain M., Rook A., Freytes C. O., Craig F., et al. Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. Blood 1998; 91: 399
   PubMed Web of Science ®Google Scholar
• Moreland L. W., Sewell K. L., Trentham D. E., Bucy R. P., Sullivan W. F., Schrohenloher R. E., Shmerling R. H., Parker K. C., Swartz W. G., Woodworth T. G., et al. Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension. Arthritis Rheum. 1995; 38: 1177
   PubMed Web of Science ®Google Scholar
• Bousvaros A., Stevens A. C., Strom T. B., Murphy J., Lamont J. T. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes. Dig. Dis. Sci. 1997; 42: 1542
   Google Scholar
• Bagel J., Garland W. T., Breneman D., Holick M., Littlejohn T. W., Crosby D., Faust H., Fivenson D., Nichols J. Administration of DAB389IL-2 to patients with recalcitrant psoriasis: A double-blind, phase II multicenter trial. J. Am. Acad. Dermatol. 1998; 38: 938
   PubMed Web of Science ®Google Scholar
• Gottlieb S. L., Gilleaudeau P., Johnson R., Estes L., Woodworth T. G., Gottlieb A. B., Krueger J. G. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat. Med. 1995; 1: 442
   PubMed Web of Science ®Google Scholar
• Woodworth T. G., Nichols J. C. Recombinant fusion toxins—A new class of targeted biologic therapeutics. Cancer Treat. Res. 1993; 68: 145
   PubMedGoogle Scholar
• Frankel A. E., McCubrey J. A., Miller M. S., Delatte S., Ramage J., Kiser M., Kucera G. L., Alexander R. L., Beran M., Tagge E. P., et al. Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias. Leukemia 2000; 14: 576
   PubMed Web of Science ®Google Scholar
• Chan C. H., Blazar B. R., Greenfield L., Kreitman R. J., Vallera D. A. Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells. Blood 1996; 88: 1445
   Google Scholar
• Vallera D. A., Seo S. Y., Panoskaltsis-Mortari A., Griffin J. D., Blazar B. R. Targeting myeloid leukemia with a DT[390]-mIL-3 fusion immunotoxin: Ex vivo and in vivo studies in mice. Protein Eng. 1999; 12: 779
   PubMedGoogle Scholar
• Liger D., vanderSpek J. C., Gaillard C., Cansier C., Murphy J. R., Leboulch P., Gillet D. Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4ser)2-mIL-3. FEBS Lett. 1997; 406: 157
   Google Scholar
• Cai J., Zheng T., Murphy J., Waters C. A., Lin G. Y., Gill P. S. IL-4R expression in Aids-Ks Cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4). Invest. New Drugs 1997; 15: 279
   PubMed Web of Science ®Google Scholar
• Chadwick D. E., Jean L. F., Jamal N., Messner H. A., Murphy J. R., Minden M. D. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein. Br. J. Haematol. 1993; 85: 25
   PubMed Web of Science ®Google Scholar
• Masood R., Lunardi-Iskandar Y., Jean L. F., Murphy J. R., Waters C., Gallo R. C., Gill P. Inhibition of AIDS-associated kaposi's sarcoma cell growth by DAB389-interleukin 6. AIDS Res. Hum. Retrovir. 1994; 10: 969
   Google Scholar
• Sweeney E. B., Foss F. M., Murphy J. R., vanderSpek J. C. Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: A novel agent for the elimination of IL-7 receptor positive cells. Bioconjug. Chem. 1998; 9: 201
   PubMed Web of Science ®Google Scholar
• vanderSpek J. C., Sutherland J., Sampson E., Murphy J. R. Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15. Protein Eng. 1995; 8: 1317
   Google Scholar
• Vallera D. A., Panoskaltsis-Mortari A., Blazar B. R. Renal dysfunction accounts for the dose limiting toxicity of DT390anti-CD3scFv, a potential new recombinant anti-GVHD immunotoxin. Protein Eng. 1997; 10: 1071
   PubMedGoogle Scholar
• Ma S., Hu H., Thompson J., Stavrou S., Scharff J., Neville D. M., Jr. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin. Bioconjug. Chem. 1997; 8: 695
   Google Scholar
• Aullo P., Alcami J., Popoff M. R., Klatzmann D. R., Murphy J. R., Boquet P. A recombinant diphtheria toxin related human CD4 fusion protein specifically kills HIV infected cells which express gp120 but selects fusion toxin resistant cells which carry HIV. EMBO J. 1992; 11: 575
   PubMed Web of Science ®Google Scholar
• LeMaistre C. F., Meneghetti C., Howes L., Osborne C. K. Targeting the EGF receptor in breast cancer treatment. Breast Cancer Res. Treat. 1994; 32: 97
   PubMed Web of Science ®Google Scholar
• Landgraf R., Pegram M., Slamon D. J., Eisenberg D. Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1. Biochemistry 1998; 37: 3220
   Google Scholar
• Batoz M., Coll Fresno P. M., Pizette S., Raffioni S., Birnbaum D., Coulier F. A diphtheria toxin/fibroblast growth factor 6 mitotoxin selectivity kills fibroblast growth factor receptor-expressing cell lines. Cell Growth Differ. 1995; 6: 1143
   PubMedGoogle Scholar
• Chadwick D. E., Williams D. P., Niho Y., Murphy J. R., Minden M. D. Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cells. Leuk. Lymphoma 1993; 11: 249
   PubMed Web of Science ®Google Scholar
• Hotchkiss C. E., Hall P. D., Cline J. M., Willingham M. C., Kreitman R. J., Gardin J., Latimer A., Ramage J., Feely T., DeLatte S., et al. Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeys. Toxicol. Appl. Pharmacol. 1999; 158: 152
   PubMed Web of Science ®Google Scholar
• vanderSpek J. C., Sutherland J. A., Zeng H., Battey J. F., Jensen R. T., Murphy J. R. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP. Cancer Res. 1997; 57: 290
   PubMed Web of Science ®Google Scholar
• Tatro J. B., Wen Z., Entwistle M. L., Atkins M. B., Smith T. J., Reichlin S., Murphy J. R. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases. Cancer Res. 1992; 52: 2545
   Google Scholar
• Benoliel R., Eliav E., Mannes A. J., Caudle R. M., Leeman S., Iadarola M. J. Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain 1999; 79: 243
   Google Scholar
• Fisher C. E., Sutherland J. A., Krause J. E., Murphy J. R., Leeman S. E., vanderSpek J. C. Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: In vitro destruction of cells bearing substance P receptors. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 7341
   Google Scholar
• Francis J. W., Brown R. H., Jr., Figueiredo D., Remington M. P., Castillo O., Schwarzschild M. A., Fishman P. S., Murphy J. R., vanderSpek J. C. Enhancement of diphtheria toxin potency by replacement of the receptor binding domain with tetanus toxin C-fragment: A potential vector for delivering heterologous proteins to neurons. J. Neurochem. 2000; 74: 2528
   PubMed Web of Science ®Google Scholar
• Arora N., Masood R., Zheng T., Cai J., Smith D. L., Gill P. S. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res. 1999; 59: 183
   PubMed Web of Science ®Google Scholar